ZRO’s Competitive Advantage

The ZRO is a non-incisional, transcervical female sterilization device. The ZRO will compete with both traditional surgical tubal ligation and other transcervical sterilization devices.

The ZRO has tremendous benefits over surgical tubal ligation. The ZRO procedure is minimally invasive resulting in no incisions or scars. The procedure may be easily performed in an office based setting and requires local or no anesthesia. The ZRO procedure lowers the likelihood of post-operative pain and reduces the recovery time to less than one day compared to three to five days or more for surgical procedures.

The total cost of the ZRO procedure is considerably less than surgical tubal ligation. The reduced recovery time also lowers overall costs associated with recovery and work loss.

This device is not FDA approved. Not for sale in the U.S.